Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$30.68 - $40.09 $225,774 - $295,022
7,359 Added 11.68%
70,357 $2.16 Million
Q2 2023

Aug 02, 2023

BUY
$36.12 - $47.5 $293,149 - $385,510
8,116 Added 14.79%
62,998 $2.52 Million
Q1 2023

Apr 26, 2023

BUY
$35.53 - $43.38 $259,582 - $316,934
7,306 Added 15.36%
54,882 $2.24 Million
Q4 2022

Feb 01, 2023

BUY
$38.19 - $57.45 $210,617 - $316,836
5,515 Added 13.11%
47,576 $1.84 Million
Q3 2022

Oct 28, 2022

BUY
$51.24 - $58.89 $324,707 - $373,185
6,337 Added 17.74%
42,061 $2.24 Million
Q2 2022

Aug 04, 2022

SELL
$51.49 - $81.64 $235,618 - $373,584
-4,576 Reduced 11.35%
35,724 $2.08 Million
Q1 2022

May 03, 2022

SELL
$60.03 - $76.49 $607,203 - $773,696
-10,115 Reduced 20.06%
40,300 $3.08 Million
Q4 2021

Jan 31, 2022

BUY
$47.97 - $62.21 $107,404 - $139,288
2,239 Added 4.65%
50,415 $3.03 Million
Q3 2021

Oct 27, 2021

BUY
$54.64 - $61.3 $473,564 - $531,287
8,667 Added 21.94%
48,176 $2.7 Million
Q2 2021

Jul 23, 2021

BUY
$59.18 - $69.99 $498,118 - $589,105
8,417 Added 27.07%
39,509 $2.4 Million
Q1 2021

Apr 27, 2021

SELL
$59.31 - $78.82 $476,199 - $632,845
-8,029 Reduced 20.52%
31,092 $2.18 Million
Q4 2020

Feb 03, 2021

BUY
$50.47 - $66.26 $87,363 - $114,696
1,731 Added 4.63%
39,121 $2.34 Million
Q3 2020

Oct 27, 2020

SELL
$51.97 - $63.0 $437,171 - $529,956
-8,412 Reduced 18.37%
37,390 $2.25 Million
Q2 2020

Aug 04, 2020

SELL
$30.8 - $52.47 $168,044 - $286,276
-5,456 Reduced 10.64%
45,802 $2.4 Million
Q4 2019

Jan 31, 2020

SELL
$36.31 - $46.83 $161,289 - $208,018
-4,442 Reduced 7.97%
51,258 $2.32 Million
Q3 2019

Oct 23, 2019

BUY
$35.66 - $44.99 $1.99 Million - $2.51 Million
55,700 New
55,700 $2.12 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.